Evaluation of assays for measurement of serum (anti)oxidants in hemodialysis patients

Tatjana Ruskovska, Eugene H J M Jansen, Risto Antarorov, Tatjana Ruskovska, Eugene H J M Jansen, Risto Antarorov

Abstract

Background: Various biomarkers and assays have been used for assessment of (anti)oxidant status in hemodialysis patients, including those intended for measurement of serum total (anti)oxidants, most often as a part of panel biomarkers.

Methods: Serum (anti)oxidant status was measured in 32 chronically hemodialyzed patients and in 47 healthy persons, using two oxidations and three antioxidant assays.

Results: The patients before the hemodialysis session have had higher values of total oxidants in comparison to the healthy persons, with a further increase during the hemodialysis. These findings were confirmed with both oxidation assays, but they differ in the percentage of increase and the statistical significance. All three antioxidant assays showed significantly higher values of the total serum antioxidants in the patients before the hemodialysis session in comparison to the healthy persons, and their significant decrease during the hemodialysis. However, the assays differ in the percentage of decrease, its statistical significance, and the correlations with uric acid.

Conclusion: The variability of results of total (anti)oxidants which are obtained using different assays should be taken into account when interpreting data from clinical studies of oxidative stress, especially in complex pathologies such as chronic hemodialysis.

Figures

Figure 1
Figure 1
Serum oxidants in patients on chronic hemodialysis and healthy persons. *Statistically significant difference between patients before and after the single hemodialysis session. ***Statistically significant difference between patients after hemodialysis and healthy persons.
Figure 2
Figure 2
Serum antioxidants in patients on chronic hemodialysis and healthy persons. *Statistically significant difference between patients before and after the single hemodialysis session. **Statistically significant difference between patients before hemodialysis and healthy persons. ***Statistically significant difference between patients after hemodialysis and healthy persons.

References

    1. Puchades MJ, Saez G, Muñoz MC, et al. Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clinical Nephrology. 2013;80(3):177–186.
    1. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P. Vascular incompetence in dialysis patients—protein-bound uremic toxins and endothelial dysfunction. Seminars in Dialysis. 2011;24(3):327–337.
    1. Dahe GJ, Teotia RS, Kadam SS, Bellare JR. The biocompatibility and separation performance of antioxidative polysulfone/vitamin E TPGS composite hollow fiber membranes. Biomaterials. 2011;32(2):352–365.
    1. Shi XF, Ding F, Zhu QY, et al. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients. Renal Failure. 2005;27(2):213–219.
    1. Vaziri ND. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. The American Journal of Kidney Diseases. 2013;61(6):992–1000.
    1. Bossola M, Vulpio C, Colacicco L, Scribano D, Zuppi C, Tazza L. Reactive oxygen metabolites (ROMs) are associated with cardiovascular disease in chronic hemodialysis patients. Clinical Chemistry and Laboratory Medicine. 2012;50(8):1447–1453.
    1. Honda H, Ueda M, Kojima S, et al. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients. Atherosclerosis. 2012;220(2):493–501.
    1. Ari E, Kaya Y, Demir H, et al. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients. Hemodialysis International. 2011;15(4):453–459.
    1. Celik G, Yöntem M, Bilge M, Cilo M, Ünaldi M. The relationship between the antioxidant system and anaemia in haemodialysis patients. Journal of International Medical Research. 2011;39(5):1954–1960.
    1. Rusu A, Rusu F, Zalutchi D, Muresan A, Caprioara MG, Kacso I. The influence of vitamin E supplementation on erythropoietin responsiveness in chronic hemodialysis patients with low levels of erythrocyte superoxide dismutase. International Urology and Nephrology. 2013;45(2):495–501.
    1. Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M. Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder. Journal of Renal Nutrition. 2012;22(1):98–101.
    1. Suvakov S, Damjanovic T, Stefanovic A, et al. Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. Nephrology Dialysis Transplantation. 2013;28(1):202–212.
    1. Muñoz-Cortés M, Cabré C, Villa D, et al. Oxidative stress and other risk factors for white matter lesions in chronic hemodialysis patients. Clinical Nephrology. 2013;80(3):187–197.
    1. Gerardi G, Usberti M, Martini G, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clinical Chemistry and Laboratory Medicine. 2002;40(2):104–110.
    1. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S. Reduction of serum antioxidative capacity during hemodialysis. Clinical and Experimental Nephrology. 2007;11(3):218–224.
    1. Montazerifar F, Hashemi M, Karajibani M, Dikshit M. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans. Journal of Medicinal Food. 2010;13(6):1490–1493.
    1. Namiduru ES, Tarakcioglu M, Tiryaki O, Usalan C. Evaluation of oxidative and nitrosative stress in hemodialysis patients. Minerva Medica. 2010;101(5):305–310.
    1. Jansen EH, Beekhof PK, Cremers JW, Viezeliene D, Muzakova V, Skalicky J. Long-term stability of parameters of antioxidant status in human serum. Free Radical Research. 2013;47(6-7):535–540.
    1. Diacron. 2012,
    1. Rel Assay Diagnostics.
    1. Alberti A, Bolognini L, Macciantelli D, Caratelli M. The radical cation of N,N-diethl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Research on Chemical Intermediates. 2000;26(3):253–267.
    1. Verde V, Fogliano V, Ritieni A, Maiani G, Morisco F, Caporaso N. Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma. Free Radical Research. 2002;36(8):869–873.
    1. Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry. 2005;38(12):1103–1111.
    1. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical Biochemistry. 1996;239(1):70–76.
    1. Jansen EH, Ruskovska T. Comparative analysis of serum (anti)oxidative status parаmeters in healthy persons. International Journal of Molecular Sciences. 2013;14(3):6106–6115.
    1. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry. 2004;37(4):277–285.
    1. The BAP test and the global assessement of oxidative stress in clinical practice. Release 4.1, 2010, .
    1. Dodatak PB. Osnovne Statisticke Metode Za Nematematicare. 2nd edition. Zagreb, Croatia: SNL; 1985. (Manualia Universitatis Studiorum Zagrabiensis).
    1. Samouilidou E, Grapsa E, Karpouza A, Lagouranis A. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis. Blood Purification. 2007;25(2):175–178.
    1. Coaccioli S, Standoli ML, Biondi R, et al. Open comparison study of oxidative stress markers between patients with chronic renal failure in conservative therapy and patients in haemodialysis. Clinica Terapeutica. 2010;161(5):435–439.
    1. Pompella A, Sies H, Wacker R, et al. The use of “total antioxidant capacity” as surrogate marker for food quality and its impact on health is to be discouraged. Nutrition. 2014
    1. Rysz J, Stolarek RA, Pedzik A, Nowicki M, Nowak D. Serum antioxidant capacity is preserved in peritoneal dialysis contrary to its robust depletion after hemodialysis and hemodiafiltration sessions. Therapeutic Apheresis and Dialysis. 2010;14(2):209–217.
    1. Kuppusamy UR, Indran M, Ahmad T, Wong SW, Tan SY, Mahmood AA. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Clinica Chimica Acta. 2005;351(1-2):197–201.
    1. Khaira A, Mahajan S, Kumar A, et al. Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis. Renal Failure. 2011;33(4):411–417.
    1. Castilla P, Echarri R, Dávalos A, et al. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. The American Journal of Clinical Nutrition. 2006;84(1):252–262.
    1. Erdoğan C, Unlüçerçi Y, Türkmen A, Kuru A, Cetin O, Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clinica Chimica Acta. 2002;322(1-2):157–161.
    1. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clinical Chemistry. 1995;41(8, part 1):1135–1138.
    1. Horoz M, Bolukbas C, Bolukbas FF, et al. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infectious Diseases. 2006;6, article 114
    1. Dimitrijevic ZM, Cvetkovic TP, Djordjevic VM, et al. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients. International Journal of Medical Sciences. 2012;9(9):808–815.
    1. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry. 2004;37(2):112–119.
    1. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology. 2001;54(5):356–361.
    1. Carollo C, Lo Presti R, Caimi G. Leukocyte activation markers and oxidative status in chronic kidney disease. Minerva Urologica e Nefrologica. 2013;65(1):69–76.
    1. Nassiri AA, Hakemi MS, Soulati M, Marashian M, Rahbar K, Azizi F. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease. Iranian Journal of Kidney Diseases. 2009;3(3):162–167.
    1. Ishii T, Ohtake T, Okamoto K, et al. Serum biological antioxidant potential predicts the prognosis of hemodialysis patients. Nephron Clinical Practice . 2011;117(3):c230–c236.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren